Bayer AG (Germany) Today
| BAYN Stock | EUR 19.42 0.06 0.31% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Bayer AG is trading at 19.42 as of the 29th of November 2024. This is a 0.31% up since the beginning of the trading day. The stock's lowest day price was 19.2. Bayer AG has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Bayer AG NA are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of October 2024 and ending today, the 29th of November 2024. Click here to learn more.
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany. BAYER AG is traded on Frankfurt Stock Exchange in Germany. The company has 982.42 M outstanding shares. More on Bayer AG NA
Moving together with Bayer Stock
Moving against Bayer Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Bayer Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Bayer AG's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Bayer AG or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Drug Manufacturers—General, Healthcare (View all Sectors) |
Bayer AG NA (BAYN) is traded on Frankfurt Exchange in Germany and employs 102,296 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 56.05 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bayer AG's market, we take the total number of its shares issued and multiply it by Bayer AG's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Bayer AG NA operates under Healthcare sector and is part of Drug Manufacturers—General industry. The entity has 982.42 M outstanding shares.
Bayer AG NA has accumulated about 8.19 B in cash with 5.09 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.34.
Check Bayer AG Probability Of Bankruptcy
Ownership AllocationBayer AG holds a total of 982.42 Million outstanding shares. 30% of Bayer AG NA outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Bayer Ownership Details
Bayer AG NA Risk Profiles
Although Bayer AG's alpha and beta are two of the key measurements used to evaluate Bayer AG's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.64 | |||
| Standard Deviation | 2.58 | |||
| Variance | 6.67 | |||
| Risk Adjusted Performance | (0.15) |
Bayer Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Bayer AG without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Competition Analyzer Now
Competition AnalyzerAnalyze and compare many basic indicators for a group of related or unrelated entities |
| All Next | Launch Module |
Bayer AG Corporate Management
Elected by the shareholders, the Bayer AG's board of directors comprises two types of representatives: Bayer AG inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bayer. The board's role is to monitor Bayer AG's management team and ensure that shareholders' interests are well served. Bayer AG's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bayer AG's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sarena Lin | Labor Officer | Profile | |
| Oliver Maier | Head Relations | Profile | |
| Gabriel Harnier | Patents Law | Profile | |
| Heiko Schipper | Member Division | Profile | |
| Rodrigo Santos | Member Division | Profile | |
| Michael Preuss | Gov Communications | Profile | |
| Stefan Oelrich | Head Management | Profile |
Other Information on Investing in Bayer Stock
Bayer AG financial ratios help investors to determine whether Bayer Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bayer with respect to the benefits of owning Bayer AG security.